Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Titel:
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Auteur:
Fisher, Benjamin A Veenith, Tonny Slade, Daniel Gaskell, Charlotte Rowland, Matthew Whitehouse, Tony Scriven, James Parekh, Dhruv Balasubramaniam, Madhu S Cooke, Graham Morley, Nick Gabriel, Zoe Wise, Matthew P Porter, Joanna McShane, Helen Ho, Ling-Pei Newsome, Philip N Rowe, Anna Sharpe, Rowena Thickett, David R Bion, Julian Gates, Simon Richards, Duncan Kearns, Pamela